States / Louisiana / HR 174

HR 174 Reported from Committee

DRUGS/TESTING: Requests the state surgeon general and the Louisiana Department of Health to assess the feasibility of advancing fenbendazole or similar treatments for potential human use in cancer treatment and to provide guidance on engaging federal authorities for expedited evaluation while protecting public health

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Compare versions →
HR174 Enrolled — · 544 words Open full page ↗

ENROLLED

2026 Regular Session

HOUSE RESOLUTION NO. 174

BY REPRESENTATIVES OWEN, AMEDEE, BERAULT, WILFORD CARTER,

CARVER, HORTON, SCHAMERHORN, AND TAYLOR

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.